Fig. 3From: Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of boneProgression-free survival curves at 4 months (4-month PFS) in eight patients rendered macroscopically free of disease following chemotherapy and metastasectomy (2sCR) versus 4-month PFS in the remaining 43 patients (no-2CR2); 2sCR: surgical complete remissionBack to article page